1 year return (CAGR)
-63.93%
Chemomab Therapeutics Ltd DRC Exchange (NASDAQ, USD)
CMMB
1.10
+0.05 (+4.76%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-56.41%
5 year return (CAGR)
-63.07%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
8.06M
Price/Sales
-
Ent value
3.61M
Price/Book
0.93
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-39.04%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.05 |
| Daily high | 1.15 |
| Daily low | 1.04 |
| Daily Volume | 22K |
| All-time high | 38092.80 |
| 1y analyst estimate | 5.00 |
| Beta | 0.76 |
| EPS (TTM) | -0.95 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CMMB | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.87% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 26 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -92.21% | -10.65% |
| Avg time to new high | 485 days | 12 days |
| Max time to new high | 1936 days | 1805 days |
News
